ACRX - Arcellx upgraded at HC Wainwright on likely authorization of anticoagulant
2023-08-18 18:33:45 ET
More on AcelRx Pharmaceuticals
- AcelRx Pharmaceuticals launches ~$10M private placement of shares
- AcelRx adds 16% on plans to divest pain therapy
- AcelRx announces $7.5M direct offering of common stock and warrants
- AcelRx Pharma rises 8% on positive data from post-operative pain management therapy
For further details see:
Arcellx upgraded at HC Wainwright on likely authorization of anticoagulant